|1.||Rigopoulos, Angela: 2 articles (05/2014 - 08/2012)|
|2.||White, Jonathan M: 2 articles (05/2014 - 08/2012)|
|3.||O'Keefe, Graeme J: 2 articles (05/2014 - 08/2012)|
|4.||Cao, Diana: 2 articles (05/2014 - 08/2012)|
|5.||Yeoh, Shinn Dee: 2 articles (05/2014 - 08/2012)|
|6.||Tochon-Danguy, Henri J: 2 articles (05/2014 - 08/2012)|
|7.||Laurens, Evelyn: 2 articles (05/2014 - 08/2012)|
|8.||Cartwright, Glenn A: 2 articles (05/2014 - 08/2012)|
|9.||Scott, Andrew M: 2 articles (05/2014 - 08/2012)|
|10.||Ackermann, Uwe: 2 articles (05/2014 - 08/2012)|
01/01/2013 - "The identification of these novel sulfoxides from garlic accumulates a great deal of new chemistry in the Allium sulfide field, and future pharmacological investigations of these compounds will aid the development of natural, healthy foods and anti-cancer agents that may prevent or combat disease. "
08/27/1998 - "The sulfoxides were more active than the sulfides as cytotoxic agents in a variety of human cancer cell cultures with the activities of the sulfoxides approaching that of brefeldin A itself. "
02/01/1994 - "Cyclic imides such as N-substituted alkyl ethers, thioethers, sulfoxides, sulfones and related derivatives were potent agents against human single cell tumors and selected solid tumor growths, eg adenocarcinoma of the colon and glioma. "
05/01/2014 - "In order to develop hypoxia imaging agents with faster kinetics, we have synthesised and evaluated several F-18 labelled anilino sulfoxides. "
11/02/2000 - "In general, the diaryl sulfoxides (4, 5, and 7-9) showed much greater hypoxia selectivity (11-27-fold) than the alkylaryl sulfoxides (approximately 3-fold) (1 and 3). "
11/02/2000 - "The fused diphenyl sulfoxides (10 and 11), on the other hand, showed very low hypoxia selectivity (1.3-3-fold). "
|5.||Neurodegenerative Diseases (Neurodegenerative Disease)
05/22/2014 - "The antioxidative properties of the target compounds are more potent than that of 1, and the antineuroinflammatory properties are less strong than that of 1. According to the parallel artificial membrane permeation assay for the blood-brain barrier, target compounds possess greater blood-brain barrier (BBB) permeability than 1. In short, due to improvement of the antioxidative effect, stability, and BBB permeability, (E)-3,4-dihydroxystyryl aralkyl sulfones and sulfoxides can thus be considered as potential multifunctional neuroprotective agents and serve as new lead candidates in the treatment of neurodegenerative diseases. "
|6.||Artificial Membranes (Artificial Membrane)